SEARCH

SEARCH BY CITATION

References

  • Autry A. E. and Monteggia L. M. (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238258.
  • Autry A. E., Adachi M., Nosyreva E., Na E. S., Los M. F., Cheng P. F., Kavalali E. T. and Monteggia L. M. (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 9195.
  • Bailey J., Ma D. and Szumlinski K. K. (2012) Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization. Addict. Biol. 17, 248258.
  • Barak S., Liu F., Ben Hamida S., Yowell Q. V., Neasta J., Kharazia V., Janak P. H. and Ron D. (2013) Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat. Neurosci. 16, 11111117.
  • Bekinschtein P., Katche C., Slipczuk L. N., Igaz L. M., Cammarota M., Izquierdo I. and Medina J. H. (2007) mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol. Learn. Mem. 87, 303307.
  • Belelovsky K., Kaphzan H., Elkobi A. and Rosenblum K. (2009) Biphasic activation of the mTOR pathway in the gustatory cortex is correlated with and necessary for taste learning. J. Neurosci. 29, 74247431.
  • Ben Hamida S., Neasta J., Lasek A. W., Kharazia V., Zou M., Carnicella S., Janak P. H. and Ron D. (2012) The small G protein H-Ras in the mesolimbic system is a molecular gateway to alcohol-seeking and excessive drinking behaviors. J. Neurosci. 32, 1584915858.
  • Blundell J., Kouser M. and Powell C. M. (2008) Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation. Neurobiol. Learn. Mem. 90, 2835.
  • Cammalleri M., Lutjens R., Berton F., King A. R., Simpson C., Francesconi W. and Sanna P. P. (2003) Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 1436814373.
  • Costa-Mattioli M. and Monteggia L. M. (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat. Neurosci. 16, 15371543.
  • Costa-Mattioli M., Sossin W. S., Klann E. and Sonenberg N. (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron 61, 1026.
  • Cozzoli D. K., Goulding S. P., Zhang P. W. et al. (2009) Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J. Neurosci. 29, 86558668.
  • Cui Y., Zhang X. Q., Xin W. J., Jing J. and Liu X. G. (2010) Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats. Neuroscience 171, 134143.
  • Davies S. P., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95105.
  • Dayas C. V., Smith D. W. and Dunkley P. R. (2012) An emerging role for the Mammalian target of rapamycin in “pathological” protein translation: relevance to cocaine addiction. Front. Pharmacol. 3, 13.
  • Dazert E. and Hall M. N. (2011) mTOR signaling in disease. Curr. Opin. Cell Biol. 23, 744755.
  • Dehay B., Bove J., Rodriguez-Muela N., Perier C., Recasens A., Boya P. and Vila M. (2010) Pathogenic lysosomal depletion in Parkinson's disease. J. Neurosci. 30, 1253512544.
  • Deli A., Schipany K., Rosner M., Hoger H., Pollak A., Li L., Hengstschlager M. and Lubec G. (2012) Blocking mTORC1 activity by rapamycin leads to impairment of spatial memory retrieval but not acquisition in C57BL/6J mice. Behav. Brain Res. 229, 320324.
  • Demirkan G., Yu K., Boylan J. M., Salomon A. R. and Gruppuso P. A. (2011) Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mTORC1). PLoS ONE 6, e21729.
  • Derkinderen P., Valjent E., Toutant M., Corvol J. C., Enslen H., Ledent C., Trzaskos J., Caboche J. and Girault J. A. (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23, 23712382.
  • Domanskyi A., Geissler C., Vinnikov I. A., Alter H., Schober A., Vogt M. A., Gass P., Parlato R. and Schutz G. (2011) Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB J. 25, 28982910.
  • Dowling R. J., Topisirovic I., Fonseca B. D. and Sonenberg N. (2010) Dissecting the role of mTOR: Lessons from mTOR inhibitors. Biochim. Biophys. Acta 1804, 433439.
  • Gafford G. M., Parsons R. G. and Helmstetter F. J. (2011) Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus. Neuroscience 182, 98104.
  • Girault J. A., Valjent E., Caboche J. and Herve D. (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 7785.
  • Glover E. M., Ressler K. J. and Davis M. (2010) Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories. Learn. Mem. 17, 577581.
  • Gobert D., Topolnik L., Azzi M., Huang L., Badeaux F., Desgroseillers L., Sossin W. S. and Lacaille J. C. (2008) Forskolin induction of late-LTP and up-regulation of 5' TOP mRNAs translation via mTOR, ERK, and PI3K in hippocampal pyramidal cells. J. Neurochem. 106, 11601174.
  • Goncalves J., Baptista S., Olesen M. V., Fontes-Ribeiro C., Malva J. O., Woldbye D. P. and Silva A. P. (2012) Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment. J. Neurochem. 123, 10411053.
  • Gong R., Park C. S., Abbassi N. R. and Tang S. J. (2006) Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J. Biol. Chem. 281, 1880218815.
  • Halloran J., Hussong S., Burbank R. et al. (2012) Chronic inhibition of mTOR by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience 223, 102113.
  • Harris H. and Rubinsztein D. C. (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108117.
  • Hartford C. M. and Ratain M. J. (2007) Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin. Pharmacol. Ther. 82, 381388.
  • Hay N. and Sonenberg N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 19261945.
  • Hernandez D., Torres C. A., Setlik W. et al. (2012) Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74, 277284.
  • Hoeffer C. A. and Klann E. (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 6775.
  • Hoeffer C. A., Tang W., Wong H. et al. (2008) Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60, 832845.
  • Hosokawa N., Hara T., Kaizuka T. et al. (2009) Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 19811991.
  • Hsu P. P., Kang S. A., Rameseder J. et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 13171322.
  • Hyman S. E., Malenka R. C. and Nestler E. J. (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565598.
  • Jaworski J. and Sheng M. (2006) The growing role of mTOR in neuronal development and plasticity. Mol. Neurobiol. 34, 205219.
  • Jernigan C. S., Goswami D. B., Austin M. C., Iyo A. H., Chandran A., Stockmeier C. A. and Karolewicz B. (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 17741779.
  • Jobim P. F., Pedroso T. R., Christoff R. R., Werenicz A., Maurmann N., Reolon G. K. and Roesler R. (2012a) Inhibition of mTOR by rapamycin in the amygdala or hippocampus impairs formation and reconsolidation of inhibitory avoidance memory. Neurobiol. Learn. Mem. 97, 105112.
  • Jobim P. F., Pedroso T. R., Werenicz A., Christoff R. R., Maurmann N., Reolon G. K., Schroder N. and Roesler R. (2012b) Impairment of object recognition memory by rapamycin inhibition of mTOR in the amygdala or hippocampus around the time of learning or reactivation. Behav. Brain Res. 228, 151158.
  • Koob G. F. and Volkow N. D. (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35, 217238.
  • Koren I., Reem E. and Kimchi A. (2010) Autophagy gets a brake: DAP1, a novel mTOR substrate, is activated to suppress the autophagic process. Autophagy 6, 11791180.
  • Kwiatkowski D. J. and Manning B. D. (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14 Spec No. 2, R251R258.
  • Lamming D. W. and Sabatini D. M. (2013) A central role for mTOR in lipid homeostasis. Cell Metab. 18, 465469.
  • Lamming D. W., Ye L., Katajisto P. et al. (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 16381643.
  • Laplante M. and Sabatini D. M. (2012) mTOR signaling in growth control and disease. Cell 149, 274293.
  • Laplante M. and Sabatini D. M. (2013) Regulation of mTORC1 and its impact on gene expression at a glance. J. Cell Sci. 126, 17131719.
  • Lee C. C., Huang C. C., Wu M. Y. and Hsu K. S. (2005) Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J. Biol. Chem. 280, 1854318550.
  • Li N., Lee B., Liu R. J., Banasr M., Dwyer J. M., Iwata M., Li X. Y., Aghajanian G. and Duman R. S. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959964.
  • Liao L., Pilotte J., Xu T., Wong C. C., Edelman G. M., Vanderklish P. and Yates J. R., 3rd (2007) BDNF induces widespread changes in synaptic protein content and up-regulates components of the translation machinery: an analysis using high-throughput proteomics. J. Proteome Res. 6, 10591071.
  • Lin J., Liu L., Wen Q., Zheng C., Gao Y., Peng S., Tan Y. and Li Y. (2014) Rapamycin prevents drug seeking via disrupting reconsolidation of reward memory in rats. Int. J. Neuropsychopharmacol. 17, 127136.
  • Liu K., Lu Y., Lee J. K. et al. (2010) PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 10751081.
  • Liu-Yesucevitz L., Bassell G. J., Gitler A. D., Hart A. C., Klann E., Richter J. D., Warren S. T. and Wolozin B. (2011) Local RNA translation at the synapse and in disease. J. Neurosci. 31, 1608616093.
  • Lovinger D. M., White G. and Weight F. F. (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243, 17211724.
  • Lu L., Koya E., Zhai H., Hope B. T. and Shaham Y. (2006) Role of ERK in cocaine addiction. Trends Neurosci. 29, 695703.
  • Lu P., Wang Y., Graham L. et al. (2012) Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150, 12641273.
  • Ma X. M. and Blenis J. (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307318.
  • Ma X. M., Yoon S. O., Richardson C. J., Julich K. and Blenis J. (2008) SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133, 303313.
  • Mac Callum P. E., Hebert M., Adamec R. E. and Blundell J. (2013) Systemic inhibition of mTOR kinase via rapamycin disrupts consolidation and reconsolidation of auditory fear memory. Neurobiol. Learn. Mem. S1074-7427(13)00173-1.
  • Maiese K., Chong Z. Z., Shang Y. C. and Wang S. (2013) mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol. Med. 19, 5160.
  • Majumder S., Caccamo A., Medina D. X., Benavides A. D., Javors M. A., Kraig E., Strong R., Richardson A. and Oddo S. (2012) Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell 11, 326335.
  • Mameli M., Balland B., Lujan R. and Luscher C. (2007) Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 317, 530533.
  • Mazei-Robison M. S., Koo J. W., Friedman A. K. et al. (2011) Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 72, 977990.
  • Mendoza M. C., Er E. E. and Blenis J. (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 36, 320328.
  • Miller C. A. and Marshall J. F. (2005) Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47, 873884.
  • Myskiw J. C., Rossato J. I., Bevilaqua L. R., Medina J. H., Izquierdo I. and Cammarota M. (2008) On the participation of mTOR in recognition memory. Neurobiol. Learn. Mem. 89, 338351.
  • Narita M., Akai H., Kita T. et al. (2005) Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats. Neuroscience 132, 553560.
  • Neasta J., Ben Hamida S., Yowell Q., Carnicella S. and Ron D. (2010) Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proc. Natl Acad. Sci. USA 107, 2009320098.
  • Neasta J., Ben Hamida S., Yowell Q. V., Carnicella S. and Ron D. (2011) AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biol. Psychiatry 70, 575582.
  • Nestler E. J. (2005) Is there a common molecular pathway for addiction? Nat. Neurosci. 8, 14451449.
  • Ozaita A., Puighermanal E. and Maldonado R. (2007) Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J. Neurochem. 102, 11051114.
  • Park K. K., Liu K., Hu Y., Kanter J. L. and He Z. (2010) PTEN/mTOR and axon regeneration. Exp. Neurol. 223, 4550.
  • Polakiewicz R. D., Schieferl S. M., Gingras A. C., Sonenberg N. and Comb M. J. (1998) mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J. Biol. Chem. 273, 2353423541.
  • Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R. and Ozaita A. (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 11521158.
  • Puighermanal E., Busquets-Garcia A., Gomis-Gonzalez M., Marsicano G., Maldonado R. and Ozaita A. (2013) Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology 38, 13341343.
  • Ron D. and Messing R. O. (2013) Signaling pathways mediating alcohol effects. Curr. Top. Behav. Neurosci. 13, 87126.
  • Ron D. and Wang J. (2009) The NMDA receptor and alcohol, in Biology of the NMDA Receptor (Van Dongen AM., ed.), Chapter 4. CRC Press, Boca Raton, FL.
  • Russo S. J., Dietz D. M., Dumitriu D., Morrison J. H., Malenka R. C. and Nestler E. J. (2010) The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci. 33, 267276.
  • Sanchis-Segura C. and Spanagel R. (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. 11, 238.
  • Santini E., Heiman M., Greengard P., Valjent E. and Fisone G. (2009) Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Sci. Signal. 2, ra36.
  • Sarbassov D. D., Ali S. M., Sengupta S., Sheen J. H., Hsu P. P., Bagley A. F., Markhard A. L. and Sabatini D. M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159168.
  • Schratt G. M., Nigh E. A., Chen W. G., Hu L. and Greenberg M. E. (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 24, 73667377.
  • Shehata M., Matsumura H., Okubo-Suzuki R., Ohkawa N. and Inokuchi K. (2012) Neuronal stimulation induces autophagy in hippocampal neurons that is involved in AMPA receptor degradation after chemical long-term depression. J. Neurosci. 32, 1041310422.
  • Slipczuk L., Bekinschtein P., Katche C., Cammarota M., Izquierdo I. and Medina J. H. (2009) BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS ONE 4, e6007.
  • Spanagel R. (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol. Rev. 89, 649705.
  • Sparks C. A. and Guertin D. A. (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29, 37333744.
  • Spilman P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R. and Galvan V. (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5, e9979.
  • Steketee J. D. and Kalivas P. W. (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol. Rev. 63, 348365.
  • Stoica L., Zhu P. J., Huang W., Zhou H., Kozma S. C. and Costa-Mattioli M. (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl Acad. Sci. USA 108, 37913796.
  • Stuber G. D., Hopf F. W., Tye K. M., Chen B. T. and Bonci A. (2010) Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Curr. Top. Behav. Neurosci. 3, 327.
  • Sui L., Wang J. and Li B. M. (2008) Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn. Mem. 15, 762776.
  • Sutton M. A. and Schuman E. M. (2006) Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127, 4958.
  • Swiech L., Perycz M., Malik A. and Jaworski J. (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim. Biophys. Acta 1784, 116132.
  • Szumlinski K. K., Kalivas P. W. and Worley P. F. (2006) Homer proteins: implications for neuropsychiatric disorders. Curr. Opin. Neurobiol. 16, 251257.
  • Takei N., Inamura N., Kawamura M., Namba H., Hara K., Yonezawa K. and Nawa H. (2004) Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 24, 97609769.
  • Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N. and Schuman E. M. (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467472.
  • Thoreen C. C., Chantranupong L., Keys H. R., Wang T., Gray N. S. and Sabatini D. M. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109113.
  • Torres C. A. and Sulzer D. (2012) Macroautophagy can press a brake on presynaptic neurotransmission. Autophagy 8, 15401541.
  • Tzschentke T. M. (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12, 227462.
  • Valjent E., Corvol J. C., Pages C., Besson M. J., Maldonado R. and Caboche J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 87018709.
  • Valjent E., Pages C., Rogard M., Besson M. J., Maldonado R. and Caboche J. (2001) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci. 14, 342352.
  • Valjent E., Pages C., Herve D., Girault J. A. and Caboche J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci. 19, 18261836.
  • Vanderschuren L. J. and Pierce R. C. (2010) Sensitization processes in drug addiction. Curr. Top. Behav. Neurosci. 3, 179195.
  • Vezina C., Kudelski A. and Sehgal S. N. (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28, 721726.
  • Wang J., Carnicella S., Phamluong K., Jeanblanc J., Ronesi J. A., Chaudhri N., Janak P. H., Lovinger D. M. and Ron D. (2007) Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: implications for alcohol drinking behavior. J. Neurosci. 27, 35933602.
  • Wang J., Lanfranco M. F., Gibb S. L., Yowell Q. V., Carnicella S. and Ron D. (2010a) Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse. J. Neurosci. 30, 1018710198.
  • Wang X., Luo Y. X., He Y. Y., Li F. Q., Shi H. S., Xue L. F., Xue Y. X. and Lu L. (2010b) Nucleus accumbens core mammalian target of rapamycin signaling pathway is critical for cue-induced reinstatement of cocaine seeking in rats. J. Neurosci. 30, 1263212641.
  • Weston M. C., Chen H. and Swann J. W. (2012) Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J. Neurosci. 32, 1144111452.
  • Wong E. and Cuervo A. M. (2010) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb. Perspect. Biol. 2, a006734.
  • Wu J., McCallum S. E., Glick S. D. and Huang Y. (2011) Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization. Neuroscience 172, 104109.
  • Yang H., Rudge D. G., Koos J. D., Vaidialingam B., Yang H. J. and Pavletich N. P. (2013) mTOR kinase structure, mechanism and regulation. Nature 497, 217223.
  • Yip C. K., Murata K., Walz T., Sabatini D. M. and Kang S. A. (2010) Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 38, 768774.
  • Yu Y. H., Yoon S. O., Poulogiannis G. et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 13221326.
  • Zhu P. J., Huang W., Kalikulov D. et al. (2011) Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma-mediated disinhibition. Cell 147, 13841396.
  • Zoncu R., Efeyan A. and Sabatini D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 2135.